Misa Vreca

Misa Vreca

Auto-generated profile, based on publicly available information

Misa Vreca

Institute of Molecular Genetics and Genetic Engineering, Belgrade

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2018 in The Journal of Gene Medicine
Verified
Journal Article
Closed access
PDF file
DSDuško Spasovski
Duško Spasovski
VSVesna Spasovski
Vesna Spasovski
ZBZoran Baščarević
Zoran Baščarević
MSMaja Stojiljković
Maja Stojiljković
MVMiša Vreća
Miša Vreća
SPSonja Pavlović
Sonja Pavlović

1 December 2018 in Immunology Letters
Verified
Journal Article
Closed access
MVMisa Vreca
Misa Vreca
MAMarina Andjelkovic
Marina Andjelkovic
NTNatasa Tosic
Natasa Tosic
AZAna Zekovic
Ana Zekovic
NDNemanja Damjanov
Nemanja Damjanov
VSVesna Spasovski
Vesna Spasovski

16 November 2017 in Journal of Applied Genetics
Verified
Journal Article
Closed access
PDF file
MVMiša Vreća
Miša Vreća
AZAna Zeković
Ana Zeković
NDNemanja Damjanov
Nemanja Damjanov
MAMarina Andjelkovic
Marina Andjelkovic
MUMilena Ugrin
Milena Ugrin
VSVesna Spasovski
Vesna Spasovski

1 January 2015 in Genetika
Verified
Journal Article
Open access
PDF file
VSVesna Skodric-Trifunovic
Vesna Skodric-Trifunovic
IBIvana Buha
Ivana Buha
DJDragana Jovanovic
Dragana Jovanovic
VVVioleta Vucinic
Violeta Vucinic
MSMihailo Stjepanovic
Mihailo Stjepanovic
SPSonja Pavlovic
Sonja Pavlovic
Tuberculosis (TB) is granulomatous diseases caused by Mycobacterium tuberculosis (MTB). TB is a highly infectious disease that primarily affects the lungs. One-third of human population is infected with MTB, therefore it is of utmost significance to determine the factors that influence the individual susceptibility to the disease. Host genetic factors have been recognized as essential for susceptibility to TB, since only 5% to 10% of infected individuals develop the disease. A number of candidate genes has been intensively studied, the most of which were connected with the function of macrophages, thus participating in immune response. Here we examined the gene variants of VDR (FokI) and NRAMP1 (INT4, D543N, 3?UTR) genes in aim to make the correlation between these genetic factors and risk of TB in Serbian patients. This study included 110 TB patients and 67 healthy controls. Pulmonary TB was diagnosed by clinical symptoms, radiological evidence of TB and bacteriological criteria (Culture- positive/ smear- positive). Genotyping was performed using PCR-RFLP method. Our findings revealed significant prevalence of ff genotype and variant allele f of the FokI VDR gene variant in patients compared to control group. Based on the our results the carriers of ff genotype are five times more at risk to tuberculosis than carriers of FF and Ff genotype in our population. The results of analyzed SNPs in NRAMP1 gene showed no statistically significant difference in distribution of the gene variants between patient and control groups. Therefore, we could conclude that the genotype ff of the VDR gene is factor that strongly contribute to susceptibility to TB in Serbian population.


1 January 2019 in Archives of Biological Sciences
Verified
Journal Article
Open access
PDF file
DLDarija Loncaric
Darija Loncaric
BSBiljana Stankovic
Biljana Stankovic
AGAmani Ghousein
Amani Ghousein
MVMiša Vreća
Miša Vreća
VSVesna Spasovski
Vesna Spasovski
SPSonja Pavlovic
Sonja Pavlovic
A major limitation in the development of efficient clinical protocols for mesenchymal stromal cell (MStroC)-based tissue regeneration therapy is the low retention and survival of MStroC in injured tissue after therapeutic administration. Low oxygen concentration preconditioning (LOP) during ex vivo cultivation of MStroC, as a method for mimicking oxygenation in their physiological microenvironment, has been shown to be beneficial in clinical trials using MStroC. Introducing hypoxia-mimicking molecules into MStroC during cultivation could be an advantageous LOP strategy. MicroRNA (miRNA) drugs are good candidates for this approach. Analysis of the expression of miRNA-210 in human bone marrow-derived MStroC in conditions of acute and extended hypoxia (24 to 72 h) was performed using RT-qPCR methodology. HIF-1? and HIF-2? gene knockdown cell lines were generated using lentiviral transduction of short hairpin RNA (shRNA) in order to examine whether miRNA-210 expression is regulated by transcription factor HIF-1 and/or HIF-2. We detected a significant increase in miRNA-210 expression in hypoxic conditions at time points of 24, 48 and 72 h (p<0.05). Knocking down of HIF-1? and HIF-2? genes indicated involvement of both transcription factors in the elevation of miRNA-210 expression. These results point to miRNA-210 as a good candidate for a hypoxia-mimicking molecule in LOP strategy.